Key result
Pharmacy-based protocol tests FINDRISC and point-of-care HbA1c screening to detect undiagnosed T2DM.
Why the study?
Does community pharmacy-based point-of-care testing using FINDRISC and HbA1c improve the early detection of undiagnosed type 2 diabetes mellitus?
Population
Adults without a prior diagnosis of diabetes visiting selected community pharmacies in Irbid Governorate…
Design
Other
Follow-up
6 months
Authors
Loading...
This study protocol describes a community pharmacy-based screening pathway to improve early detection and referral of undiagnosed type 2 diabetes.
Does community pharmacy-based point-of-care testing using FINDRISC and HbA1c improve the early detection of undiagnosed type 2 diabetes mellitus?
This study protocol describes a community pharmacy-based screening pathway to improve early detection and referral of undiagnosed type 2 diabetes.
Alshorman et al. (2026) studied Type 2 diabetes mellitus (T2DM). Community pharmacy-based point-of-care testing (POCT) for diabetes screening was evaluated on Proportion of individuals at high risk for T2DM and the prevalence of previously undiagnosed dysglycaemia. This study protocol describes a community pharmacy-based screening program using FINDRISC and point-of-care HbA1c testing to identify undiagnosed type 2 diabetes; no results are reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: